Comparison with Tirzepatide and Semaglutide Retatrutide distinguishes itself from existing treatments like Tirzepatide and semaglutide through its triple hormone receptor agonism
Population-based studies consistently demonstrate that individuals with CVDs face a significantly elevated risk of developing cognitive impairment, including dementia [1, 2]
The stack stimulates your own growth hormone, not replacing it
The GSH and oxidized glutathione (GSSG) detection assay demonstrated a significant elevation in the GSH/GSSG ratio within P3O, suggesting mitigation of oxidative stress (Fig
The mTORC1 and mTORC2 respond to growth factors, but only mTORC1 is influenced by glucose and amino acids (Jewell and Guan, 2013)
If you are still losing weight steadily on Retatrutide alone, there is no urgent reason to add a second compound